The European Industrial Biotechnology Innovation and Synthetic Biology Accelerator (EU-IBISBA) is a distributed RI that provides translational Research & Development & Innovation services to an international community of industrial biotechnology stakeholders, including academia, SMEs and industry. EU-IBISBA contributes to the growth of biotechnology, providing academics and industry with a unique opportunity to access services and expertise necessary to move early-stage research results towards higher maturity and innovation. It delivers services at the exit point of basic and early stage applied research, and provides support for concept proofing, prototyping, upscaling and piloting, to bridge the innovation gap that separates academic research from industrial demonstration and premarket development.
The IBISBA concept emerged as early as 2013 and a significant milestone in his history is the launch of IBISBA 1.0, a starting community project that has provided the means to perform foundational work and develop a subsidized transnational access program for biotechnology. Entered the ESFRI Roadmap 2018, EU-IBISBA is in the Preparation Phase to develop and operate a one-stop portal for its services. The scientific and technological capabilities of IBISBA are developed within the framework of Member Country investments and local management. Most of the facilities contributing to IBISBA are identified as parts of nationally based Research Infrastructure. Currently, IBISBA gathers research facilities owned by universities and Research & Technology Organisations from seven European countries.